Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Biorxiv : the Preprint Server for Biology
|
July 9, 2020
Mutations from bat ACE2 orthologs markedly enhance ACE2-Fc neutralization of SARS-CoV-2
Huihui Mou, Brian D Quinlan, Haiyong Peng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 14, 2024
In vivo evolution of env in SHIV-AD8<sub>EO</sub>-infected rhesus macaques after AAV-vectored delivery of eCD4-Ig
Daniel O'Hagan, Siddhartha Shandilya, Lincoln J Hopkins, et al.
Journal of Virology
|
August 13, 2010
Envelope-modified single-cycle simian immunodeficiency virus selectively enhances antibody responses and partially protects against repeated, low-dose vaginal challenge
Michael D Alpert, Andrew R Rahmberg, William Neidermyer, et al.
Plos Pathogens
|
April 9, 2021
Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2
Huihui Mou, Brian D Quinlan, Haiyong Peng, et al.
Journal of Virology
|
March 30, 2012
A nonfucosylated variant of the anti-HIV-1 monoclonal antibody b12 has enhanced FcγRIIIa-mediated antiviral activity in vitro but does not improve protection against mucosal SHIV challenge in macaques
Brian Moldt, Mami Shibata-Koyama, Eva G Rakasz, et al.
Molecular Therapy. Advances
|
May 15, 2026
<i>In vivo</i> HSC gene therapy enables sustained eCD4-Ig expression for SIV prevention
Chang Li, Anna K Anderson, Anne-Sophie Kuhlmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 20, 2014
Live simian immunodeficiency virus vaccine correlate of protection: local antibody production and concentration on the path of virus entry
Qingsheng Li, Ming Zeng, Lijie Duan, et al.
Journal of Virology
|
August 17, 2012
Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family
Mattia Bonsignori, Justin Pollara, M Anthony Moody, et al.
Science Translational Medicine
|
March 21, 2014
Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination
Nicole L Yates, Hua-Xin Liao, Youyi Fong, et al.
The Journal of Clinical Investigation
|
August 9, 2014
FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial
Shuying S Li, Peter B Gilbert, Georgia D Tomaras, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Biorxiv : the Preprint Server for Biology
|
July 9, 2020
Mutations from bat ACE2 orthologs markedly enhance ACE2-Fc neutralization of SARS-CoV-2
Huihui Mou, Brian D Quinlan, Haiyong Peng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 14, 2024
In vivo evolution of env in SHIV-AD8<sub>EO</sub>-infected rhesus macaques after AAV-vectored delivery of eCD4-Ig
Daniel O'Hagan, Siddhartha Shandilya, Lincoln J Hopkins, et al.
Journal of Virology
|
August 13, 2010
Envelope-modified single-cycle simian immunodeficiency virus selectively enhances antibody responses and partially protects against repeated, low-dose vaginal challenge
Michael D Alpert, Andrew R Rahmberg, William Neidermyer, et al.
Plos Pathogens
|
April 9, 2021
Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2
Huihui Mou, Brian D Quinlan, Haiyong Peng, et al.
Journal of Virology
|
March 30, 2012
A nonfucosylated variant of the anti-HIV-1 monoclonal antibody b12 has enhanced FcγRIIIa-mediated antiviral activity in vitro but does not improve protection against mucosal SHIV challenge in macaques
Brian Moldt, Mami Shibata-Koyama, Eva G Rakasz, et al.
Molecular Therapy. Advances
|
May 15, 2026
<i>In vivo</i> HSC gene therapy enables sustained eCD4-Ig expression for SIV prevention
Chang Li, Anna K Anderson, Anne-Sophie Kuhlmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 20, 2014
Live simian immunodeficiency virus vaccine correlate of protection: local antibody production and concentration on the path of virus entry
Qingsheng Li, Ming Zeng, Lijie Duan, et al.
Journal of Virology
|
August 17, 2012
Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family
Mattia Bonsignori, Justin Pollara, M Anthony Moody, et al.
Science Translational Medicine
|
March 21, 2014
Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination
Nicole L Yates, Hua-Xin Liao, Youyi Fong, et al.
The Journal of Clinical Investigation
|
August 9, 2014
FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial
Shuying S Li, Peter B Gilbert, Georgia D Tomaras, et al.
Page
of 3